The Potential Role of Biomarkers Associated with ASCVD Risk: Risk-Enhancing Biomarkers

Serum cholesterol is major risk factor and contributor to atherosclerotic cardiovascular disease (ASCVD). Therapeutic cholesterol-lowering drugs, especially statin, revealed that reduction in low-density lipoprotein cholesterol (LDL-C) produces marked reduction of ASCVD events. In the preventive sco...

Descripción completa

Detalles Bibliográficos
Autor principal: Choi, Seonghoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Lipidology and Atherosclerosis 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379121/
https://www.ncbi.nlm.nih.gov/pubmed/32821707
http://dx.doi.org/10.12997/jla.2019.8.2.173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379121/
https://www.ncbi.nlm.nih.gov/pubmed/32821707
http://dx.doi.org/10.12997/jla.2019.8.2.173

Ejemplares similares